Semaglutide Cost: What You'll Actually Pay for GLP-1 Weight Loss Therapy

For most people considering GLP-1 therapy, cost is the single biggest barrier to entry. The pricing landscape around semaglutide is genuinely confusing — brand-name Ozempic, FDA-approved Wegovy, compounded formulations, telehealth subscriptions, and clinic programs all carry different price tags with different levels of care attached. Some patients pay over $1,500 per month. Others access the same active molecule for a fraction of that.

The short answer: Brand-name Wegovy runs $1,300 to $1,700 per month without insurance. Compounded semaglutide through a medically supervised clinic typically costs $300 to $600 per month — including provider oversight, titration, and monitoring. The difference in price is significant. The difference in what you receive for that price is even more significant.

This guide breaks down what semaglutide actually costs across every available pathway, what you should expect to receive for your money, and where the hidden expenses tend to surface. If you are evaluating semaglutide therapy for weight loss, this is the transparency you deserve before making a decision.

Understanding the Semaglutide Landscape

Semaglutide is a GLP-1 receptor agonist — a class of medications originally developed for type 2 diabetes that demonstrated remarkable weight loss efficacy in clinical trials. The molecule itself is the same regardless of the brand or formulation. What differs is the FDA indication, the delivery mechanism, and the price.

Ozempic is manufactured by Novo Nordisk and FDA-approved for type 2 diabetes management. It is widely prescribed off-label for weight loss. The dosing maxes out at 2.0 mg per week, and it comes in a pre-filled injection pen.

Wegovy is also manufactured by Novo Nordisk and contains the exact same semaglutide molecule. The difference is regulatory: Wegovy carries FDA approval specifically for chronic weight management and is dosed up to 2.4 mg per week.

Compounded semaglutide is produced by compounding pharmacies using the same active pharmaceutical ingredient. These formulations are legally manufactured under FDA oversight (either 503A or 503B regulations) and offer significant cost savings because they are not subject to the same brand-name pricing structures.

All three contain semaglutide. All three activate the same GLP-1 receptors. The differences are regulatory, commercial, and financial — not pharmacological.

Brand-Name Pricing: What Ozempic and Wegovy Actually Cost

The retail pricing for brand-name semaglutide is substantial and continues to rise.

Ozempic (off-label for weight loss)

• Without insurance: $900 to $1,200 per month
• With insurance (diabetes indication): $25 to $150 per month copay
• With insurance (off-label weight loss): Often denied or requires extensive prior authorization
• Manufacturer savings card: Can reduce cost to $25/month for commercially insured patients, but excludes government insurance and has eligibility restrictions

Wegovy (FDA-approved for weight loss)

• Without insurance: $1,300 to $1,700 per month
• With insurance (if covered): $50 to $300 per month copay
• Coverage rates: Approximately 50 percent of commercial insurance plans offer some Wegovy coverage, though many impose strict requirements
• Manufacturer savings program: Available but limited in scope and duration

The reality is that even with insurance, many patients face significant out-of-pocket costs. Prior authorization delays, step therapy requirements (where insurers require you to fail on cheaper medications first), and annual coverage caps all create friction that extends well beyond the sticker price.

Compounded Semaglutide Pricing

Compounded semaglutide has become the most accessible pathway for patients who want medically supervised GLP-1 therapy without brand-name pricing.

Typical Cost Range

• Monthly cost: $300 to $600 per month
• Savings vs. brand-name: 60 to 80 percent less expensive
• What affects price: Dosage level, pharmacy source, and what clinical services are bundled with the medication

What “Compounded” Actually Means

Compounding is the pharmaceutical practice of creating customized medications tailored to individual patient needs. For semaglutide, compounding pharmacies obtain pharmaceutical-grade semaglutide base and formulate it into injectable preparations at specific dosages.

This is not a grey market. Compounding pharmacies operate under federal and state regulations. However, not all compounding pharmacies are equal — and this distinction matters significantly for quality and safety.

503A vs. 503B Pharmacy Distinction

503A pharmacies compound medications based on individual patient prescriptions. They operate under state board of pharmacy oversight and are not required to follow current Good Manufacturing Practices (cGMP). Quality control varies.

503B outsourcing facilities operate under direct FDA oversight and must follow cGMP standards — the same manufacturing quality standards that apply to traditional pharmaceutical manufacturers. They can produce larger batches, undergo regular FDA inspections, and maintain more rigorous testing protocols.

When evaluating a clinic’s compounded semaglutide program, the pharmacy source is one of the most important questions to ask. A 503B-sourced product carries substantially more quality assurance than a 503A formulation, though both are legal and regulated.

What to Look For in Quality

• Sterility testing on every batch
• Potency verification through third-party testing
• Beyond-use dating supported by stability studies
• Clear documentation of the semaglutide source material
• FDA registration (for 503B facilities)

What Is Included in the Cost: Clinic vs. Telehealth vs. DIY

The monthly dollar amount is only meaningful in context of what you receive. Three distinct models have emerged in the medical weight loss space, and they deliver vastly different value.

Telehealth Prescription Services: $199 to $399/month

These platforms typically offer:

• Brief online questionnaire or short video consultation
• Prescription sent to a compounding pharmacy
• Medication shipped to your home
• Minimal or no ongoing monitoring
• Limited access to a provider for dosing questions
• No lab work or metabolic assessment

The appeal is convenience and low cost. The limitation is that you are largely managing a powerful medication on your own, with little to no clinical oversight guiding your titration or monitoring your metabolic response.

Specialized Medical Clinic: $300 to $600/month

A comprehensive clinic program typically includes:

• Initial medical evaluation and metabolic assessment
• Prescription and medication (sourced from vetted pharmacies)
• Structured titration protocol with provider guidance
• Regular check-ins and dosage adjustments
• Metabolic monitoring and diagnostic testing
• Side effect management
• Nutritional and lifestyle guidance
• Long-term planning including taper and maintenance strategies

The Long-Term Cost Equation

The cheapest monthly option is not always the cheapest outcome. Patients who begin semaglutide without proper titration frequently experience:

• Severe nausea and GI side effects (leading to discontinuation)
• Suboptimal dosing that produces minimal results
• No metabolic tracking, missing early signs of nutritional deficiency or thyroid changes
• Rapid weight regain after stopping due to lack of a maintenance protocol

Each of these scenarios carries its own cost — whether that is wasted months on an ineffective dose, emergency medical visits for unmanaged side effects, or starting over entirely after regaining lost weight.

Hidden Costs to Watch For

Not every semaglutide program is priced transparently. Before committing to any provider, ask specifically about these common additional charges.

Mandatory subscription packages. Some telehealth platforms require 3 to 6 month commitments with limited cancellation options. If the medication does not work for you or side effects are intolerable, you may still owe for remaining months.

Labs charged separately. Basic metabolic panels, thyroid function tests, and other monitoring labs may not be included in the quoted monthly price. These can add $200 to $500 per quarter depending on what is ordered and whether your insurance covers lab work.

Consultation fees on top of medication. Some providers quote the medication cost alone, then charge separately for each provider visit, dosage adjustment, or follow-up call.

No refund or cancellation policies. Read the fine print. If you need to stop treatment, understand what financial obligations remain.

Cost of managing poorly supervised side effects. An ER visit for pancreatitis symptoms, imaging for gallbladder concerns, or specialist referrals for persistent GI issues — these are downstream costs that proper medical supervision helps prevent.

The Real Cost of Not Being Supervised

Semaglutide is not a simple medication. It modulates appetite signaling, gastric motility, insulin sensitivity, and multiple metabolic pathways simultaneously. Without appropriate medical oversight, patients face meaningful clinical risks.

Gallbladder complications. Rapid weight loss increases gallstone risk. Semaglutide accelerates this timeline. Regular monitoring can catch early warning signs before a gallbladder emergency — which carries its own five-figure hospital bill.

Thyroid concerns. GLP-1 receptor agonists carry a boxed warning regarding thyroid C-cell tumors observed in rodent studies. While human risk appears low, thyroid function monitoring is a non-negotiable component of responsible prescribing.

Muscle loss from rapid weight loss. Without metabolic monitoring, patients can lose significant lean mass alongside fat — particularly if protein intake is inadequate or the rate of weight loss is too aggressive. This compromises metabolic health long-term and makes weight maintenance more difficult.

Nutritional deficiencies. Reduced appetite and food intake can lead to deficiencies in vitamins, minerals, and protein that are only detectable through lab work. Left unaddressed, these deficiencies create fatigue, hair loss, immune suppression, and other issues that undermine quality of life.

Weight regain. Perhaps the most expensive hidden cost. Clinical data consistently shows that patients who discontinue semaglutide without a structured taper and maintenance plan regain a majority of lost weight within 12 months. Every dollar spent on the initial weight loss phase is effectively wasted without a long-term strategy.

This is precisely why working with a specialized clinic — one that monitors, adjusts, and plans beyond the active weight loss phase — delivers fundamentally different outcomes than a prescription alone.

Insurance vs. Cash Pay: A Detailed Comparison

For semaglutide specifically, the insurance pathway involves several layers of complexity that are worth understanding before you commit to either route.

The Insurance Pathway

Prior authorization. Nearly all insurers require prior authorization for Wegovy and off-label Ozempic. This process involves your provider submitting clinical documentation proving medical necessity. Turnaround time ranges from 48 hours to several weeks, and denial rates are significant.

Step therapy requirements. Many insurers require documented failure on cheaper weight loss interventions before approving GLP-1 therapy. This may mean 3 to 6 months on older medications (phentermine, orlistat, etc.) before semaglutide is authorized — regardless of what your provider recommends.

BMI thresholds. Insurance coverage typically requires a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity. Patients who fall just below these thresholds — even those who would benefit significantly from treatment — are excluded.

Coverage instability. Insurance formularies change annually. A medication covered this year may not be covered next year, creating abrupt disruptions in treatment.

Quantity limits and dose caps. Some plans limit how long you can remain on Wegovy or cap the approved dosage below what your provider determines is clinically appropriate.

The Cash Pay Pathway

Immediate access. No prior authorization, no step therapy, no delays. Treatment begins when you and your provider agree it is appropriate.

Consistent pricing. Monthly costs are predictable and not subject to formulary changes or benefit redesigns.

Provider autonomy. Your prescribing physician determines dosage and duration based on your clinical response — not an insurance company’s cost containment protocols.

Privacy. GLP-1 therapy does not appear on insurance claims, which some patients prefer for personal or professional reasons.

No BMI gatekeeping. Treatment decisions are made between you and your provider based on comprehensive metabolic assessment, not an arbitrary BMI threshold.

For many patients, the cash pay pathway through a specialized clinic offers more predictable costs, faster access, and fewer administrative barriers — even when insurance coverage is theoretically available.

How Semaglutide Compares to Other GLP-1 Options

Semaglutide is not the only GLP-1 receptor agonist available. Tirzepatide therapy (the molecule in Mounjaro and Zepbound) is a dual GIP/GLP-1 agonist that some patients respond to more favorably. Pricing for tirzepatide follows a similar structure — brand-name products carry premium pricing while compounded formulations offer greater accessibility.

Your provider should evaluate which molecule is most appropriate for your metabolic profile, your response pattern, and your goals. Cost should inform but not dictate that clinical decision. At Rewind, our process begins with comprehensive evaluation specifically to match each patient with the optimal therapy.

The Rewind Approach

We built our semaglutide therapy program around the principles that are hardest to find in this space: transparency, quality, and comprehensive care.

Transparent pricing. We quote an all-inclusive monthly cost. No hidden consultation fees, no surprise lab charges, no mandatory long-term contracts. You know what you will pay before treatment begins.

Quality-sourced medication. Our compounded semaglutide is sourced exclusively from licensed compounding pharmacies that meet our standards for sterility testing, potency verification, and manufacturing quality.

Comprehensive monitoring. Every patient receives metabolic monitoring, structured titration, regular provider check-ins, and proactive side effect management. This is not a prescription mill — it is a medical program designed for sustainable outcomes.

No long-term contracts. Treatment continues as long as it serves your health goals. If you need to pause, adjust, or discontinue, that decision is yours without financial penalty.

Long-term planning. We do not simply prescribe semaglutide and disappear. Every patient receives a maintenance and taper strategy designed to preserve results after the active weight loss phase concludes.

Want to see what results look like? View real patient transformations →

The goal is not the cheapest possible semaglutide access. The goal is the best possible outcome per dollar invested — and that requires medical expertise, not just a prescription.

Related Articles

• Semaglutide Side Effects: What to Know Before Starting
• What Happens When You Stop Taking Semaglutide?
• Difference Between Tirzepatide and Semaglutide

References

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PubMed
2. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide. Diabetes Obes Metab. 2022;24(8):1553-1564. PubMed
3. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. PubMed
4. U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. Revised 2023.

---

Ready to find out what semaglutide would cost for you? Rewind Anti-Aging of Miami offers medically supervised semaglutide weight loss programs with transparent pricing and no long-term contracts. See how your treatment plan is designed, or schedule a consultation directly →